A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents

Journal of Cancer Research and Clinical Oncology

Volumn 118, Issue 7, 1992, Pages 509-514

  Teicher, Beverly A ^a,b   Holden, Sylvia A ^a,b   Ara, Gulshan ^a,b   Ha, Chul Soo ^a,b   Herman, Terence S ^a,b   Northey, David ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

Author keywords

Alkylating agents; Carbogen breathing; Perfluorochemical emulsion

Indexed keywords

ALKYLATING AGENT; CARBOGEN; CARMUSTINE; CYCLOPHOSPHAMIDE; FLUOSOL; MELPHALAN; OXYGENT CA; PERFLUOROOCTYL BROMIDE; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; FIBROSARCOMA; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN;

ADMINISTRATION, INHALATION; ALKYLATING AGENTS; ANIMAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBON DIOXIDE; CARMUSTINE; CELL SURVIVAL; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; EMULSIONS; FIBROSARCOMA; FLUOROCARBONS; HEMATOPOIETIC STEM CELLS; MALE; MELPHALAN; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; OXYGEN; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0026663911     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/BF01225265     Document Type: Article

References (36)

1. The clinical relevance of tumor hypoxia
2. Chemical modifiers of radiosensitivity — theory and reality: a review
3. Fluosol/oxygen in combination with cyclophosphamide in advanced non-small cell lung carcinoma (NSCLC): phase I results
4. Evaluation of oxygen diffusion distances in human breast cancer xenografts using tumor-specific in vivo data: role of various mechanisms in the development of tumor hypoxia
5. Phase I/II study of Fluosol/O2 in combination with BCNU in malignant glioma
6. Rate of infusion: an important factor in circulatory effects of perfluorochemical emulsions (PERFFLUBRONES)
7. Addition of 2-nitroimidazole radiosensitizers to trimodality therapy (cis-ciamminedichloroplatinum II/hyperthermia/radiation) in the murine FSaIIC fibrosarcoma
8. Blood flow, metabolism, cellular microenvironment and growth rate of human tumor xenografts
9. Tumor tissue oxygenation as evaluated by computerized-pO2-histography
10. The hypoxic tumor cell: a target for selective cancer chemotherapy
11. The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo
12. Phase I/II study of Fluosol/oxygen in combination with weekly 5-fluorouracil (5FU) in metastatic colorectal carcinoma
13. The radiosensitivity of a murine fibrosarcoma as measured by three cell survival assays
14. Reassessment of criteria for the selection of perfluorochemicals for second-generation blood substitutes: analysis of structure/property relationships
15. Solubility and transport in perfluorochemicals relevant to blood substitution and other biomedical applications
16. Therapeutic attack of hypoxic cells of solid tumors: Presidential address
17. Testing therapeutic hypotheses in mice and man: observations on the therapeutic activity against advanced solit tumors of man
18. A survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents
19. Perfluorochemical emulsion can increase tumor radiosensitivity
20. Selective attack of hypoxic tumor cells
21. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells
22. Differential enhancement of melphalan cytotoxicity in tumor and normal tissue by Fluosol-DA and oxygen breathing
23. Effect of Fluosol-DA/O2 on tumor cell and bone marrow cytotoxicity of nitrosoureas in mice bearing FSaII fibrosarcoma
24. Effect of Fluosol-DA/O2 on the antitumor activity and pulmonary toxicity of bleomycin
25. Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity
26. Approaches to defining the mechanism of Fluosol-DA 20%/carbogen enhancement of melphalan antitumor activity
27. The effect of Fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo
28. Effect of Fluosol-DA on the response of intracranial 9L tumors to x-rays and BCNU
29. Effect of various oxygenation conditions and Fluosol-DA on the cytotoxicity and antitumor activity of bleomycin
30. Effects of Fluosol-DA and oxygen breathin on Adriamycin antitumor activity and cardiac toxicity in mice
31. Effect of various oxygenation conditions and Fluosol-DA on cancer chemotherapeutic agents
32. Optimization of perfluorochemical levels with radiation therapy in mice
33. Evidence for enzymatic activation and oxygen invovlement in cytotoxicity and antitumour activity of N, N', N"-triethylenethiophosphoramide
34. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma
35. Oxygenation of human tumors
36. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancer by computerized O2 tension measurements